Trivascular Secures $60,000,000 Series C Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d035892f-88a6-4c69-b1fb-57bb212c95ce&Preview=1 - Date
7/13/2010 - Company Name
Trivascular - Mailing Address
3910 Brickway Blvd Santa Rosa, CA 95403 - Company Description
Trivascular is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA). - Website
http://www.trivascular2.com - Transaction Type
Venture Equity - Transaction Amount
$60,000,000 - Transaction Round
Series C - Proceeds Purposes
Proceeds from the financing will be used to launch the company’s OvationTM Abdominal Stent Graft System in Europe, drive clinical research activity across three continents, and fuel next generation product development. - M&A Terms
- Venture Investor
Pinnacle Ventures - Venture Investor
New Enterprise Associates - Venture Investor
Delphi Ventures - Venture Investor
MPM Capital - Venture Investor
Kearny Venture Partners
